Dr Agarwals Eye Hsp

₹3320 -35.8 | 1.1%

WEBSITE BSE:526783 NSE : DR.AGAR.EYE 18 May, 12:50

Market Cap ₹1560 Cr.

Stock P/E 33.7

P/B 9.9

Current Price ₹3320

Book Value ₹ 334.4

Face Value 10

52W High ₹3660

Dividend Yield 0.15%

52W Low ₹ 1350

Edit Ratio

Dr Agarwals Eye Hsp Research see more...

Overview Inc. Year: 1994Industry: Hospital & Healthcare Services

Dr. Agarwal's Eye Hospital Ltd is an eye care organisation. The Company is engaged in supplying clinic and health-associated offerings. The Company additionally affords nursing homes; clinics; clinical, studies and different institutions and institutions for eye care and treatment, and different healthcare facilities. The Company is likewise engaged in hospital-related trading and different activities. The Company gives offerings associated with cataract, glaucoma, laser correction, cornea and refractive, retina, squint, pediatric ophthalmology, neuro ophthalmology, uvea, and orbit and oculoplasty. The Company is likewise engaged in academics, such as fellowship and optometry. The Company offers its offerings in numerous places in India, such as Chennai, Bangalore, Hyderabad, Rajasthan, Andaman and Odisha, and in worldwide locations, along with Cambodia, Madagascar, Mauritius, Mozambique, Nigeria, Rwanda, Seychelles, Uganda and Zambia.

Dr Agarwals Eye Hsp Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Dr Agarwals Eye Hsp Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	56	56	66	69	64	69	78	83	76	81
Other Income	0	0	0	1	0	0	1	2	1	2
Total Income	57	56	67	70	64	70	79	86	77	83
Total Expenditure	40	39	47	50	48	48	56	61	55	56
Operating Profit	17	17	20	19	16	22	23	25	21	27
Interest	2	2	2	1	2	2	2	2	2	2
Depreciation	5	6	6	6	7	2	6	6	7	8
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	11	9	12	12	7	18	16	17	13	17
Provision for Tax	3	2	3	3	2	5	4	4	3	5
Profit After Tax	8	7	9	9	5	14	12	13	9	13
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	8	7	9	9	5	14	12	13	9	13
Adjusted Earnings Per Share	17.3	14.6	19.4	19.3	10.8	29.1	24.6	26.8	20.1	27.2

Dr Agarwals Eye Hsp Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	109	113	118	137	149	153	170	176	140	201	268	318
Other Income	1	3	0	0	2	2	2	3	2	1	2	6
Total Income	110	116	118	137	150	156	172	179	142	202	270	325
Total Expenditure	96	102	103	121	126	129	140	129	110	143	192	228
Operating Profit	14	14	15	15	24	27	32	50	32	60	78	96
Interest	4	4	4	5	4	3	4	9	7	7	8	8
Depreciation	5	6	6	11	9	10	11	21	19	20	20	27
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	4	4	5	-0	11	13	17	20	6	32	49	63
Provision for Tax	1	1	-0	-1	4	7	6	6	7	8	12	16
Profit After Tax	3	2	6	0	7	7	12	14	-1	24	37	47
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	3	2	6	0	7	7	12	14	-1	24	37	47
Adjusted Earnings Per Share	7	5.2	12.1	0.1	15.6	14.4	25.4	29.1	-3.1	51.3	78.6	98.7

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	33%	15%	12%	9%
Operating Profit CAGR	30%	16%	24%	19%
PAT CAGR	54%	38%	40%	29%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	128%	107%	63%	48%
ROE Average	39%	24%	26%	22%
ROCE Average	43%	34%	35%	27%

Dr Agarwals Eye Hsp Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	16	19	24	23	29	35	46	56	55	78	113
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	12	12	15	18	13	5	13	8	10	21	36
Other Non-Current Liabilities	1	0	-2	7	11	19	27	62	32	152	176
Total Current Liabilities	35	35	31	36	27	37	35	39	70	82	96
Total Liabilities	63	67	67	84	81	96	120	166	167	333	422
Fixed Assets	23	25	26	34	33	36	55	94	96	214	260
Other Non-Current Assets	19	19	18	27	28	37	36	43	28	69	115
Total Current Assets	22	23	23	24	20	23	30	30	44	50	47
Total Assets	63	67	67	84	81	96	120	166	167	333	422

Dr Agarwals Eye Hsp Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	4	6	2	1	2	2	2	4	6	22	28
Cash Flow from Operating Activities	11	12	14	17	20	19	25	39	34	57	70
Cash Flow from Investing Activities	-6	-11	-10	-17	-8	-11	-25	-17	-11	-46	-71
Cash Flow from Financing Activities	-3	-3	-5	-0	-12	-8	2	-20	-8	-4	0
Net Cash Inflow / Outflow	2	-3	-1	0	0	-0	2	2	15	7	-1
Closing Cash & Cash Equivalent	6	3	1	2	2	2	4	6	22	28	27

Dr Agarwals Eye Hsp Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	6.98	5.17	12.12	0.08	15.61	14.42	25.35	29.11	-3.06	51.28	78.55
CEPS(Rs)	18.87	18.04	25.22	24.29	34.21	35.23	48.57	74.29	37.58	94.66	121.49
DPS(Rs)	1.2	1.2	1.2	0.8	1.5	1.2	1.5	0	0	3	3
Book NAV/Share(Rs)	34.75	40.37	50.55	49.83	62.56	74.59	97	119.36	116.3	166.32	241.15
Core EBITDA Margin(%)	11.41	9.14	12.8	11.1	14.96	15.82	17.63	26.78	21.35	29.15	28.21
EBIT Margin(%)	7.59	6.69	7.78	2.97	10.19	10.94	12.37	16.21	9.08	19.64	21.44
Pre Tax Margin(%)	4.09	3.3	4.54	-0.35	7.39	8.71	10.25	11.33	4.1	16.06	18.44
PAT Margin (%)	2.89	2.16	4.82	0.03	4.94	4.42	7.01	7.78	-1.03	11.98	13.78
Cash Profit Margin (%)	7.83	7.53	10.03	8.36	10.83	10.8	13.42	19.85	12.63	22.11	21.31
ROA(%)	5.2	3.74	8.53	0.05	8.87	7.65	11.01	9.55	-0.86	9.63	9.78
ROE(%)	21.83	14.05	26.67	0.16	27.78	21.02	29.55	26.91	-2.6	36.29	38.56
ROCE(%)	19.22	16.58	18.81	7.7	28.26	31.7	34.3	39.87	16.92	42.4	42.98
Receivable days	15.19	15.96	18.4	20.21	19.29	16.31	16.86	15.98	20.3	15.83	12.79
Inventory Days	23.38	25.44	28.09	27.06	19.65	16.02	14.84	15.01	17.22	9.93	7.99
Payable days	132.81	137.75	307.45	344.77	321.1	315.6	312.99	238.56	351.93	347.24	320.55
PER(x)	10.34	14.12	10.31	2496.8	19.21	41.61	14.33	6.56	0	14.26	11.65
Price/Book(x)	2.08	1.81	2.47	3.91	4.8	8.04	3.75	1.6	2.69	4.39	3.8
Dividend Yield(%)	1.66	1.64	0.96	0.41	0.5	0.2	0.41	0	0	0.41	0.33
EV/Net Sales(x)	0.51	0.52	0.71	0.88	1.09	1.94	1.12	0.57	1.05	1.72	1.66
EV/Core EBITDA(x)	4.05	4.33	5.47	7.8	6.75	11.22	5.94	2.02	4.61	5.79	5.74
Net Sales Growth(%)	4.85	3.81	4.88	15.58	8.77	3.22	10.91	3.47	-20.54	43.92	33.14
EBIT Growth(%)	9.45	-8.58	22.02	-55.83	272.71	10.8	25.49	35.59	-55.51	211.36	45.34
PAT Growth(%)	96.4	-22.58	134.42	-99.36	0	-7.67	75.87	14.84	-110.51	1775.24	53.2
EPS Growth(%)	96.4	-25.87	134.42	-99.36	0	-7.67	75.87	14.84	-110.51	1775.21	53.2
Debt/Equity(x)	1.82	1.47	1.14	1.33	0.78	0.52	0.52	0.31	0.4	0.41	0.39
Current Ratio(x)	0.63	0.64	0.74	0.66	0.73	0.62	0.84	0.75	0.63	0.61	0.48
Quick Ratio(x)	0.41	0.42	0.4	0.38	0.5	0.42	0.66	0.55	0.55	0.54	0.42
Interest Cover(x)	2.17	1.97	2.4	0.89	3.64	4.92	5.82	3.32	1.82	5.48	7.14
Total Debt/Mcap(x)	0.87	0.81	0.46	0.34	0.16	0.06	0.14	0.2	0.15	0.09	0.1

Dr Agarwals Eye Hsp Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	72.38	72.15	72	71.91	71.9	71.9	71.9	71.9	71.9	71.9
FII	0	0	0	0	0	0	0	0.28	0.63	0.64
DII	0	0	0	0	0	0	0	0	0	0
Public	27.62	27.85	28	28.09	28.1	28.1	28.1	27.82	27.47	27.46
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34	0.34
FII	0	0	0	0	0	0	0	0	0	0
DII	0	0	0	0	0	0	0	0	0	0
Public	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13	0.13
Others	0	0	0	0	0	0	0	0	0	0
Total	0.47	0.47	0.47	0.47	0.47	0.47	0.47	0.47	0.47	0.47

Pros

Company has delivered good profit growth of 39% CAGR over last 5 years
Company has a good return on equity (ROE) track record: 3 Years ROE 24%
Debtor days have improved from 347.24 to 320.55days.
Company is almost debt free.

Cons

Stock is trading at 9.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Dr Agarwals Eye Hsp News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Dr Agarwals Eye Hsp

Add Watchlist

Dr Agarwals Eye Hsp Research see more...

Overview Inc. Year: 1994Industry: Hospital & Healthcare Services

Dr Agarwals Eye Hsp Share Price

Alert Data

Quarterly Price

Peer Comparison

Dr Agarwals Eye Hsp Quarterly Results

Dr Agarwals Eye Hsp Profit & Loss

Growth Rates

Dr Agarwals Eye Hsp Balance Sheet

Dr Agarwals Eye Hsp Cash Flow

Dr Agarwals Eye Hsp Ratios

Dr Agarwals Eye Hsp Shareholding Pattern

Dr Agarwals Eye Hsp News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!